| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2022 ( Subtotal = $146,616,558 ) (Continued on the next page) |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01NS128808 | Nano-Pulsed Optoacoustic Neuromodulation for Reducing Traumatic Brain Injury-Driven Neuropathology and Improving Cognitive Outcome | 000 | 1 | NIH | 5/20/2022 | $505,771 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DA053472 | Novel Addiction Neurocircuits in Cocaine Taking | 000 | 1 | NIH | 3/22/2022 | $488,840 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R61NS127286 | Developing GPR37 activators as non-opioid pain therapeutics | 000 | 1 | NIH | 3/30/2022 | $1,573,491 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R00HL153678 | Inhibiting biomechanical platelet aggregation to prevent arterial thrombosis without compromising hemostasis | 001 | 3 | NIH | 7/8/2022 | $80,560 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R00HL153678 | Inhibiting biomechanical platelet aggregation to prevent arterial thrombosis without compromising hemostasis | 000 | 3 | NIH | 3/29/2022 | $248,855 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | K01AG058789 | Improvement in Patients' Cognition and Relationship with SNF Quality Measures | 000 | 4 | NIH | 12/7/2021 | $122,508 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | D43TW012246 | Training and Research on Arboviruses and Zoonoses In Nigeria and Sierra Leone (TRAIN) | 000 | 1 | NIH | 3/8/2022 | $252,400 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | D43TW012246 | Training and Research on Arboviruses and Zoonoses In Nigeria and Sierra Leone (TRAIN) | 001 | 1 | NIH | 4/12/2022 | -$50,000 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | D43TW012246 | Training and Research on Arboviruses and Zoonoses In Nigeria and Sierra Leone (TRAIN) | 001 | 1 | NIH | 4/12/2022 | $50,000 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R25HL161715 | The University of Texas Medical Branch Summer Institute in Biostatistics and Data Science (UTMB-SIBDS) | 001 | 1 | NIH | 6/7/2022 | -$75,000 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R25HL161715 | The University of Texas Medical Branch Summer Institute in Biostatistics and Data Science (UTMB-SIBDS) | 001 | 1 | NIH | 6/7/2022 | $75,000 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R25HL161715 | The University of Texas Medical Branch Summer Institute in Biostatistics and Data Science (UTMB-SIBDS) | 000 | 1 | NIH | 1/11/2022 | $258,120 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01NS125778 | Role of microglia in neural infection | 000 | 1 | NIH | 1/12/2022 | $516,261 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI158422 | Ehrlichia Notch SLiM-activated oncoprotein inhibition of apoptosis | 000 | 1 | NIH | 10/22/2021 | $400,000 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AI164401 | Therapeutic efficacy of favipiravir against henipavirus infections | 000 | 2 | NIH | 8/2/2022 | $200,000 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AI151904 | Mechanisms by which rickettsiae subvert autophagy pathway in macrophages | 000 | 2 | NIH | 7/7/2022 | $200,000 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | K99AI156012 | Viral factors responsible for Lassa virus pathogenicity | 000 | 2 | NIH | 7/13/2022 | $113,977 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | T32AI155385 | Physician-Scientist Training in Emerging Infectious Diseases | 000 | 2 | NIH | 6/16/2022 | $189,338 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01NS122571 | Pathogenesis of HIV-associated sensory neuropathy | 000 | 2 | NIH | 7/25/2022 | $400,000 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AG066060 | Role of Neuroprotective Indoles in Delaying the Onset of Cognitive Decline | 000 | 2 | NIH | 7/19/2022 | $158,200 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AI151305 | Mechanisms of IncRNA/RBP regulation of macrophage function for control of T. cruzi infection | 000 | 2 | NIH | 3/15/2022 | $197,500 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | F31AI152422 | Roles of Pteropine Bat and Human TRIMs in Regulating Henipavirus Infection | 002 | 2 | NIH | 7/18/2022 | -$22,921 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | F31AI152422 | Roles of Pteropine Bat and Human TRIMs in Regulating Henipavirus Infection | 001 | 2 | NIH | 5/24/2022 | $716 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | F31AI152422 | Roles of Pteropine Bat and Human TRIMs in Regulating Henipavirus Infection | 000 | 2 | NIH | 3/8/2022 | $34,754 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI160226 | Preclinical development of a vaccine for Nipah virus | 000 | 2 | NIH | 2/17/2022 | $1,179,782 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AI156536 | Mincle and STING Activation in Proinflammatory Responses to Orientia Infection | 000 | 2 | NIH | 2/16/2022 | $197,500 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R00DC016328 | Determining the roles of Ca2+-binding proteins in modulation of hair cell mechanotransduction | 000 | 4 | NIH | 6/13/2022 | $359,059 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AI159703 | Ebola virus infection of the female reproductive system | 000 | 2 | NIH | 3/18/2022 | $237,000 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U7701066 | Model State-Supported Area Health Education Centers | 00 | 20 | HRSA | 7/28/2022 | $1,154,000 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG070255 | Mechanisms of Synaptic Protection in Cognitive Resilence to Alzheimer's Disease Neuropathology | 001 | 2 | NIH | 6/13/2022 | $44,275 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG070255 | Mechanisms of Synaptic Protection in Cognitive Resilence to Alzheimer's Disease Neuropathology | 000 | 2 | NIH | 3/1/2022 | $398,454 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | H4B15558 | Poison Control Stabilization and Enhancement Program | 00 | 14 | HRSA | 7/26/2022 | $504,297 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AI155844 | Developing effective nanovaccines against pathogenic Escherichia coli | 000 | 2 | NIH | 5/17/2022 | $197,500 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AI157336 | Structure and function of cloverleaf RNA in enterovirus | 000 | 2 | NIH | 5/6/2022 | $197,500 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | P01AI150585 | Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus | 000 | 2 | NIH | 4/5/2022 | $2,528,313 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG073133 | Tau oligomer conformers and synaptic vulnerability/resilience in AD and related disorders | 000 | 2 | NIH | 7/8/2022 | $779,858 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DK125730 | ANALYSIS OF INTRAHEPATIC MACROPHAGE PROFILES FOR PREDICTING RISK OF FIBROSIS DEVELOPMENT IN PATIENTS WITH DIFFERENT TYPES OF CHRONIC LIVER DISEASE | 000 | 2 | NIH | 3/30/2022 | $547,729 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | T32AG067952 | Predoctoral and Postdoctoral Training in Alzheimer's Pathophysiology | 000 | 2 | NIH | 5/25/2022 | $341,435 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01GM139034 | Structural and functional determinants of decision-making in bacteriophage host recognition | 000 | 3 | NIH | 6/20/2022 | $395,000 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U24AG072458 | Interdisciplinary Research Network on Biologically Active Tau Aggregate Polymorphs from Alzheimer's Disease and Related Dementias | 000 | 2 | NIH | 7/1/2022 | $1,544,885 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01MH128082 | Metabolic strategies to eliminate CNS Myeloid Viral Reservoirs | 000 | 2 | NIH | 5/27/2022 | $705,484 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI157852 | Modulation of BRD4 to epigenetically suppress HIV | 000 | 2 | NIH | 5/19/2022 | $601,727 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DA052263 | AIM(2)ing at the inflammasome: Impact of MAVS signaling in cocaine-and HIV-1 induced neuroinflammation | 001 | 2 | NIH | 3/29/2022 | $61,124 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DA052263 | AIM(2)ing at the inflammasome: Impact of MAVS signaling in cocaine-and HIV-1 induced neuroinflammation | 000 | 2 | NIH | 2/16/2022 | $550,093 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01ES031823 | Assessing risks for Alzheimer's disease induced by exposure to environmental pesticides | 000 | 3 | NIH | 7/12/2022 | $486,863 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01ES031823 | Assessing risks for Alzheimer's disease induced by exposure to environmental pesticides | 001 | 3 | NIH | 7/13/2022 | $400,000 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DK124132 | STING signaling in T cells regulation of intestinal homeostasis and inflammatorybowel diseases | 000 | 3 | NIH | 4/14/2022 | $503,932 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01EY031054 | Neuroprotective Role of Sirt6 in Glaucoma | 001 | 3 | NIH | 6/8/2022 | $75,084 |
| | 2022 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01HD107428 | Human placental biodisposition of novel antiherpesviral drugs, amenamevir and pritelivir, using ex vivo and in vitro experimental models | 000 | 1 | NIH | 8/11/2022 | $418,754 |
|
